SCHEMBL8419683

SCHEMBL8419683

c1ccc(-c2ncn(CCCCN3CCN(c4ncccn4)CC3)c2-c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.54
MAP4K4 O95819 1/20 0.54
FRK P42685 1/20 0.54
MAPK9 P45984 1/20 0.54
CSNK1A1 P48729 1/20 0.54
CSNK1D P48730 1/20 0.54
GSK3B P49841 1/20 0.54
PRKD2 Q9BZL6 1/20 0.54
MAP4K5 Q9Y4K4 1/20 0.54
MAPK13 O15264 10/20 0.54
MAPK12 P53778 10/20 0.54
MAPK11 Q15759 10/20 0.54
MAPK14 Q16539 10/20 0.54
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
HTR1A P08908 4/20 0.51
HTR7 P34969 2/20 0.48
DRD2 P14416 2/20 0.48
HTR2A P28223 2/20 0.48
DRD3 P35462 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6844082 0.81 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14
SCHEMBL8417646 0.79 SOAT1 (0.49) ALDH1A1TSHRHTR1AHTR7DRD2
SCHEMBL8418073 0.79 DRD2 (0.70) ALDH1A1TSHRHTR1AHTR7DRD2
SCHEMBL6847089 0.79 PRKD3 (0.54) PRKD3MAP4K4FRKMAPK9CSNK1A1
SCHEMBL8417626 0.78 FAAH (0.51) ALDH1A1TSHRHTR1AHTR7DRD2
SCHEMBL8416306 0.78 HTR1A (0.53) ALDH1A1TSHRHTR1AHTR7DRD2
SCHEMBL5847870 0.76 SIGMAR1 (0.53) PRKD3MAP4K4FRKMAPK9CSNK1A1
SCHEMBL6844336 0.76 MAPK14 (0.64) PRKD3MAP4K4FRKMAPK9CSNK1A1
SCHEMBL6161437 0.76 SIGMAR1 (0.55) PRKD3MAP4K4FRKMAPK9CSNK1A1
SCHEMBL8418064 0.75 HTR1A (0.59) HTR1AHTR7DRD2HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed